Affiner les résultats

Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment

Lugli, A. ; Went, P. ; Khanlari, B. ; Nikolova, Z. ; Dirnhofer, S.

In: Virchows Archiv, 2004, vol. 444, no. 3, p. 264-268

Meningotheliomatöses Meningeom in einem reifen zystischen Teratom des Ovars = Meningothelial meningioma in a mature cystic teratoma of the ovary

Adams, H. ; Went, P. ; Tolnay, M. ; Sartorius, G. ; Singer, G.

Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade

Winkler, D. ; Strnad, P. ; Meier, M. ; Roten, S. ; Went, P. ; Lyrer, P. ; Steck, A.

In: Journal of Neurology, 2007, vol. 254, no. 11, p. 1601-1603

A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome

Soldini, D. ; Montagna, C. ; Schüffler, P. ; Martin, V. ; Georgis, A. ; Thiesler, T. ; Curioni-Fontecedro, A. ; Went, P. ; Bosshard, G. ; Dehler, S. ; Mazzuchelli, L. ; Tinguely, M.

In: Annals of Oncology, 2013, vol. 24, no. 1, p. 193-201

Indolent lymphoma: the pathologist's viewpoint

Pileri, S. A. ; Zinzani, P. L. ; Went, P. ; Pileri Jr, A. ; Bendandi, M.

In: Annals of Oncology, 2004, vol. 15, no. 1, p. 12-18

CD5 expression in de novo diffuse large B-cell lymphomas

Went, P. ; Zimpfer, A. ; Tzankov, A. ; Dirnhofer, S.

In: Annals of Oncology, 2009, vol. 20, no. 4, p. 789-790